Setting
A total of 94 practices in four health authorities in the South Thames Region, recruiting patients over 26 months.
Subjects
Patients who consulted their general practitioner (GP) with low back pain and who had not consulted in the previous 4 weeks.
Intervention
Random allocation to immediate referral for X-ray or not.
Main outcome measures
Roland and Morris disability, Hospital Anxiety and Depression, EuroQol, Short Form with 36 items (SF-36), consultations and referrals at 6 weeks and 1 year.
Results
A total of 153 patients were recruited to the RCT, and 506 patients were recruited to the observational study.
In the RCT, referral for X-ray led to a small improvement in patient psychological well-being over the next 12 months, but there were no differences in physical outcomes, further consultations or referrals to other health professionals. Patients referred for X-ray have higher costs in the short term than patients who are not, a difference that is almost entirely due to the cost of the X-ray itself. There were no significant differences in costs over a 1-year period.
In the observational arm, referral for X-ray was associated with length of episode at presentation, which is an indicator of poor prognosis. Patients referred for X-ray had poorer physical outcomes at 6 weeks and 1 year; however, after adjustments were made for length of episode at presentation, effect sizes were similar to those in the RCT. In the observational arm, patients referred for X-ray had higher costs, both in the short term and in the long term. The poorer prognosis of patients referred for X-ray probably explains these differences.
While the study may have less internal validity than a fully randomised study of the same size, the consistency of the findings from the RCT and the observational arm support the generalisability of the results to a wider population.
Conclusions
There are few significant differences at 6 weeks or 1 year between patients who are referred for lumbar spine X-ray and those who are not. Patients who are referred appear to be in better mental health as measured within the SF-36 quality of life measure.
Implications for healthcare
• Existing guidelines are sound. Early X-ray is not indicated, although it might still be considered when patient anxiety is a major feature.
• This reinforces the message that the benefit from early X-ray is negligible and that the X-ray dose is high.
• NHS costs at 6 weeks are higher among those referred for X-ray.
Executive summary
• This study suggests that there is little evidence that early X-ray referral leads to less morbidity reflected in time off work.
Research questions
• Should there be a more active approach by GPs to encourage patients to reconsult if symptoms do not improve within 6-8 weeks? • Are there other investigations for back pain of duration greater than 8 weeks that are cost-effective?
• We also suggest a qualitative investigation into X-ray referral decisions.
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